USA – Carlsmed, a Carlsbad, CA-based spine surgery healthcare company, raised $30M in Series B funding.
The round was led by Capital Group with participation from U.S. Venture Partners, The Vertical Group, Cove Fund and Wavemaker Three-Sixty Health. Carlsmed also announced today that Robert Mittendorff, MD, MBA, General Partner and Head of Healthcare at B Capital Group, joined its Board of Directors. Widya Mulyasasmita, PhD, Senior Principal of Healthcare at B Capital Group, will also join the Board as an observer.The company intends to use the funds to ramp commercialization of aprevo®, Carlsmed’s FDA cleared personalized surgical devices.
Led by CEO Mike Cordonnier, Carlsmed uses patient data and proprietary digital technologies to create aprevo® devices, which are personalized to improve the standard of care for the surgical treatment of adults with spinal malalignment.
19/04/2022
